Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jean-Pascal Machiels

Showing results (61-70 of 164) with videos related to

Pageof 17
Sort By:
The Lancet. Oncology|March 8, 2011
Zalutumumab plus best supportive care versus best supportive care alone in patients with recurrent or metastatic squamous-cell carcinoma of the head and neck after failure of platinum-based chemotherapy: an open-label, randomised phase 3 trialJean-Pascal Machiels, Somasundaram Subramanian, Agnes Ruzsa, et al.
Life (Basel, Switzerland)|February 25, 2022
Whole Body MRI in the Detection of Lymph Node Metastases in Patients with Testicular Germ Cell CancerVassiliki Pasoglou, Sandy Van Nieuwenhove, Julien Van Damme, et al.
Acta Clinica Belgica|January 6, 2019
Neutropenia management in patients receiving myelosuppressive polychemotherapy for early breast cancer in Belgium: BRONS study resultsGaetan Catala, Jeroen Mebis, Guy Jerusalem, et al.
European Urology|February 28, 2012
Can whole-body magnetic resonance imaging with diffusion-weighted imaging replace Tc 99m bone scanning and computed tomography for single-step detection of metastases in patients with high-risk prostate cancer?Frédéric E Lecouvet, Jawad El Mouedden, Laurence Collette, et al.
Critical Reviews in Oncology/Hematology|December 3, 2021
Belgian expert consensus for tumor-agnostic treatment of NTRK gene fusion-driven solid tumors with larotrectinibAhmad Awada, Thierry Berghmans, Paul M Clement, et al.
Cancer Chemotherapy and Pharmacology|July 4, 2012
Phase I study of sorafenib in combination with docetaxel and prednisone in chemo-naïve patients with metastatic castration-resistant prostate cancerFeby Mardjuadi, Jacques Medioni, Joseph Kerger, et al.
Cancers|April 3, 2021
Preclinical Evaluation of the Association of the Cyclin-Dependent Kinase 4/6 Inhibitor, Ribociclib, and Cetuximab in Squamous Cell Carcinoma of the Head and NeckGabrielle van Caloen, Sandra Schmitz, Cédric van Marcke, et al.
The Prostate|December 31, 2013
One-step TNM staging of high-risk prostate cancer using magnetic resonance imaging (MRI): toward an upfront simplified "all-in-one" imaging approach?Vasiliki Pasoglou, Ahmed Larbi, Laurence Collette, et al.
Breast (Edinburgh, Scotland)|October 2, 2012
An exploratory study of sunitinib in combination with docetaxel and trastuzumab as first-line therapy for HER2-positive metastatic breast cancerFatima Cardoso, Jean-Luc Canon, Dino Amadori, et al.
Cancer Chemotherapy and Pharmacology|August 8, 2014
Impact of cytochrome P450 3A4 inducer and inhibitor on the pharmacokinetics of trabectedin in patients with advanced malignancies: open-label, multicenter studiesJean-Pascal Machiels, Arthur Staddon, Catherine Herremans, et al.
Pageof 17

Showing results (61-70 of 164) with videos related to

Sort By:
Pageof 17
The Lancet. Oncology|March 8, 2011
Zalutumumab plus best supportive care versus best supportive care alone in patients with recurrent or metastatic squamous-cell carcinoma of the head and neck after failure of platinum-based chemotherapy: an open-label, randomised phase 3 trialJean-Pascal Machiels, Somasundaram Subramanian, Agnes Ruzsa, et al.
Life (Basel, Switzerland)|February 25, 2022
Whole Body MRI in the Detection of Lymph Node Metastases in Patients with Testicular Germ Cell CancerVassiliki Pasoglou, Sandy Van Nieuwenhove, Julien Van Damme, et al.
Acta Clinica Belgica|January 6, 2019
Neutropenia management in patients receiving myelosuppressive polychemotherapy for early breast cancer in Belgium: BRONS study resultsGaetan Catala, Jeroen Mebis, Guy Jerusalem, et al.
European Urology|February 28, 2012
Can whole-body magnetic resonance imaging with diffusion-weighted imaging replace Tc 99m bone scanning and computed tomography for single-step detection of metastases in patients with high-risk prostate cancer?Frédéric E Lecouvet, Jawad El Mouedden, Laurence Collette, et al.
Critical Reviews in Oncology/Hematology|December 3, 2021
Belgian expert consensus for tumor-agnostic treatment of NTRK gene fusion-driven solid tumors with larotrectinibAhmad Awada, Thierry Berghmans, Paul M Clement, et al.
Cancer Chemotherapy and Pharmacology|July 4, 2012
Phase I study of sorafenib in combination with docetaxel and prednisone in chemo-naïve patients with metastatic castration-resistant prostate cancerFeby Mardjuadi, Jacques Medioni, Joseph Kerger, et al.
Cancers|April 3, 2021
Preclinical Evaluation of the Association of the Cyclin-Dependent Kinase 4/6 Inhibitor, Ribociclib, and Cetuximab in Squamous Cell Carcinoma of the Head and NeckGabrielle van Caloen, Sandra Schmitz, Cédric van Marcke, et al.
The Prostate|December 31, 2013
One-step TNM staging of high-risk prostate cancer using magnetic resonance imaging (MRI): toward an upfront simplified "all-in-one" imaging approach?Vasiliki Pasoglou, Ahmed Larbi, Laurence Collette, et al.
Breast (Edinburgh, Scotland)|October 2, 2012
An exploratory study of sunitinib in combination with docetaxel and trastuzumab as first-line therapy for HER2-positive metastatic breast cancerFatima Cardoso, Jean-Luc Canon, Dino Amadori, et al.
Cancer Chemotherapy and Pharmacology|August 8, 2014
Impact of cytochrome P450 3A4 inducer and inhibitor on the pharmacokinetics of trabectedin in patients with advanced malignancies: open-label, multicenter studiesJean-Pascal Machiels, Arthur Staddon, Catherine Herremans, et al.
Pageof 17